GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Friulchem SpA (MIL:FCM) » Definitions » Debt-to-EBITDA

Friulchem SpA (MIL:FCM) Debt-to-EBITDA : 6.88 (As of Jun. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Friulchem SpA Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Friulchem SpA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €1.54 Mil. Friulchem SpA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €10.99 Mil. Friulchem SpA's annualized EBITDA for the quarter that ended in Jun. 2023 was €1.82 Mil. Friulchem SpA's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 was 6.88.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Friulchem SpA's Debt-to-EBITDA or its related term are showing as below:

MIL:FCM' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.48   Med: 4.51   Max: 8.35
Current: 8.35

During the past 7 years, the highest Debt-to-EBITDA Ratio of Friulchem SpA was 8.35. The lowest was 1.48. And the median was 4.51.

MIL:FCM's Debt-to-EBITDA is ranked worse than
89.56% of 661 companies
in the Drug Manufacturers industry
Industry Median: 1.61 vs MIL:FCM: 8.35

Friulchem SpA Debt-to-EBITDA Historical Data

The historical data trend for Friulchem SpA's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Friulchem SpA Debt-to-EBITDA Chart

Friulchem SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial 2.81 7.27 7.15 6.20 -

Friulchem SpA Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.20 7.58 5.58 6.88 -

Competitive Comparison of Friulchem SpA's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Friulchem SpA's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Friulchem SpA's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Friulchem SpA's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Friulchem SpA's Debt-to-EBITDA falls into.



Friulchem SpA Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Friulchem SpA's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.574 + 4.495) / 1.624
=6.20

Friulchem SpA's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.541 + 10.986) / 1.82
=6.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jun. 2023) EBITDA data.


Friulchem SpA  (MIL:FCM) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Friulchem SpA Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Friulchem SpA's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Friulchem SpA (MIL:FCM) Business Description

Traded in Other Exchanges
N/A
Address
Via Carlo Ravizza 40, Milano, ITA, 20149
Friulchem SpA is an Italy based company engaged in pharma business. It is involved in research, development, and production of generic finished products such as cosmeceuticals and food supplements. The company is also involved in the manufacturing of vet-pharma products.

Friulchem SpA (MIL:FCM) Headlines

No Headlines